iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER Keyword
Keyword: hepatocellular carcinoma
Review | Open Access
Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?
Xun Qiu, Fengqiang Gao, Kai Wang, [...], Zhensheng Zhang, Chuxiao Shao, Xiao Xu << Fewer
Published: 28 March 2022
2022, 1 (1): 55-64
Review | Open Access
Advances in artificial intelligence techniques drive the application of radiomics in the clinical research of hepatocellular carcinoma
Jingwei Wei, Meng Niu, Ouyang Yabo, [...], Yu Zhou, Xiaoke Ma, Xue Yang, Hanyu Jiang, Hui Hui, Hongyi Cao, Binwei Duan, Hongjun Li, Dawei Ding, Jie Tian << Fewer
Published: 10 March 2022
2022, 1 (1): 49-54
Original Article | Open Access
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
Ying Liu, Yaqin Wang, Zhanqi Wei, [...], Tianxiao Wang, Shizhong Yang, Canhong Xiang, Xuedong Wang, Lei Gong, Jiahong Dong, Qian Lu, Yuewei Zhang << Fewer
Published: 07 March 2022
2022, 1 (1): 35-42
Review | Open Access
Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management
Jia Fu, Shou-jin Cao, Li Song, [...], Xiao-qiang Tong, Jian Wang, Min Yang, Ying-hua Zou << Fewer
Published: 01 August 2022
2022, 1 (2): 96-100
Review | Open Access
Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review
Jingxin Yan, Manjun Deng, Shunyu Kong, [...], Ting Li, Zhenwu Lei, Lushun Zhang, Yutong Zhuang, Xin He, Huanwei Wang, Haining Fan, Yingxing Guo << Fewer
Published: 04 November 2022
2022, 1 (4): 225-234
Original Article | Open Access
Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study
Chenghao Ge, Mingjie Luo, Kaiyuan Guo, [...], Dong Zhu, Ning Han, Tengjiao Wang, Xiuying Zhao << Fewer
Published: 23 November 2022
2022, 1 (4): 209-216
Original Article | Open Access
A retrospective study of PD-L1 immunohistochemistry for hepatocellular carcinoma
Min Du, Yumeng Cai, Yanrui Pang, Yuan Ji
Published: 07 September 2022
2022, 1 (3): 187-193
Original Article | Open Access
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosis
Huiying Rao, Jia Shang, Qing Xie, [...], Jianqi Lian, Pujun Gao, Junping Shi, Xinyue Chen, Jiefei Wang, Min Xu, Liaoyun Zhang, Yingren Zhao, Qing Mao, Maorong Wang, Wei Zhao, Zong Zhang, Jidong Jia, Hong Tang, Jiming Zhang, Xin Zheng, Chang Liu, Lai Wei << Fewer
Published: 12 October 2022
2022, 1 (3): 145-153
Original Article | Open Access
Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis
Hao Chi, Dapeng Chen, Yuliang Zhang, [...], Zilin Cui, Yi Bai, Yamin Zhang << Fewer
Published: 13 January 2023
2023, 2 (1): 16-25
Original Article | Open Access
A high level of secreted phosphoprotein 1 is associated with macrophage infiltration and poor prognosis in hepatocellular carcinoma
Jianping Song, Jingxian Sun, Shuhong Jing, [...], Tingxiao Zhang, Jianlei Wang, Yanfeng Liu << Fewer
Published: 19 February 2023
2023, 2 (1): 26-35
Total 23